Abstract: Disclosed is an electrosurgical instrument including an end effector with a cartridge having an asymmetric cartridge body.

Abstract: A thermal processing apparatus and method in which a first laser source, for example, a CO2 emitting at 10.6 ?m is focused onto a silicon wafer as a line beam and a second laser source, for example, a GaAs laser bar emitting at 808 nm is focused onto the wafer as a larger beam surrounding the line beam. The two beams are scanned in synchronism in the direction of the narrow dimension of the line beam to create a narrow heating pulse from the line beam when activated by the larger beam. The energy of GaAs radiation is greater than the silicon bandgap energy and creates free carriers. The energy of the CO2 radiation is less than the silicon bandgap energy so silicon is otherwise transparent to it, but the long wavelength radiation is absorbed by the free carriers.

Abstract: A surgical instrument includes an anvil and an elongate channel. The elongate channel includes a plurality of first electrical contacts and a plurality of electrical connectors comprising a plurality of second electrical contacts, wherein the electrical connectors are spring-biased such that a gap is maintained between the first electrical contacts and the second electrical contacts. The surgical instrument further includes a staple cartridge releasably attachable to the elongate channel, wherein the staple cartridge has a cartridge body comprising a plurality of staple cavities, a plurality of staples deployable from the staple cavities into the tissue, and a plurality of third electrical contacts, wherein the attachment of the staple cartridge to the elongate channel moves the electrical connectors causing the second electrical contacts to bridge the gap and become electrically coupled to the first electrical contacts.

Abstract: A power operated tailgate for a vehicle includes a major gate having a hinge about which the major gate is configured to be coupled to the vehicle for movement between open and closed positions, a minor gate configured to be coupled to the major gate for movement between open and closed positions with respect to the major gate, and a minor gate drive unit configured to drive movement of the minor gate with respect to the major gate. The minor gate is disposed at least partially within an outer profile of the major gate and supported by the major gate for movement therewith.

Abstract: An actuator for opening and closing a decklid or other closure on a motor vehicle is described and shown. The actuator can include a motor, a rod coupled to and driven by the motor, a first sleeve coupled to and driven by the rod, and a second sleeve coupled to and driven by the first sleeve. The first and second sleeves can be slidably coupled to one another, and/or can be rotatably locked relative to one another.

Abstract: The present invention provides compounds of formula I: which are useful as modulators of GPR6, pharmaceutical compositions thereof, methods for treatment of conditions associated with GPR6, processes for making the compounds and intermediates thereof.

Abstract: The present invention provides compounds of formula I: which are useful as modulators of GPR6, pharmaceutical compositions thereof, methods for treatment of conditions associated with GPR6, processes for making the compounds and intermediates thereof.

Abstract: The present invention provides compounds of formula I: which are useful as modulators of GPR6, pharmaceutical compositions thereof, methods for treatment of conditions associated with GPR6, processes for making the compounds and intermediates thereof.

Abstract: An actuator for opening and closing a decklid or other closure on a motor vehicle is described and shown. The actuator can include a motor, a rod coupled to and driven by the motor, a first sleeve coupled to and driven by the rod, and a second sleeve coupled to and driven by the first sleeve. The first and second sleeves can be slidably coupled to one another, and/or can be rotatably locked relative to one another.

Abstract: Disclosed are compounds of Formula 1, and pharmaceutically acceptable salts thereof, wherein G, p, R1, R2, R3a, R4, and R5 are defined in the specification. This disclosure also relates to materials and methods for preparing compounds of Formula 1, to pharmaceutical compositions which contain them, and to their use for treating disorders, diseases, and conditions involving the immune system and inflammation, including rheumatoid arthritis, cancer, and other disorders, diseases, and conditions for which inhibition of SYK is indicated.

Abstract: The present invention provides compounds of formula I: which are useful as modulators of GPR6, pharmaceutical compositions thereof, methods for treatment of conditions associated with GPR6, processes for making the compounds and intermediates thereof.

Abstract: Disclosed are compounds of Formula 1, and pharmaceutically acceptable salts thereof, wherein G, p, R1, R2, R3a, R4, and R5 are defined in the specification. This disclosure also relates to materials and methods for preparing compounds of Formula 1, to pharmaceutical compositions which contain them, and to their use for treating disorders, diseases, and conditions involving the immune system and inflammation, including rheumatoid arthritis, cancer, and other disorders, diseases, and conditions for which inhibition of SYK is indicated.

Abstract: Disclosed are compounds of Formula 1, and pharmaceutically acceptable salts thereof, wherein G, p, R1, R2, R3a, R4, and R5 are defined in the specification. This disclosure also relates to materials and methods for preparing compounds of Formula 1, to pharmaceutical compositions which contain them, and to their use for treating disorders, diseases, and conditions involving the immune system and inflammation, including rheumatoid arthritis, cancer, and other disorders, diseases, and conditions for which inhibition of SYK is indicated.

Abstract: Compounds, pharmaceutical compositions, kits and methods are provided for use with MEK that comprise a compound selected from the group consisting of: wherein the variables are as defined herein.

Abstract: A system and method for monitoring performance of a wireless network are disclosed. According to one described example, at least one probe is generated. In the example, the probe determines the portion of a wireless network to monitor, the type of the probe, and the number and frequency of the probe or probes to target a specific carrier, a specific system, or a specific geographical area. A probe server generates the probe based on a parameter specified by the user and transmits the probe to a plurality of posts or to the wireless network. In the example, the probe server controls the posts to send and receive probes to the wireless network. In response to the received probes, the wireless network responds by sending feedback information, which can be used to indicate how the wireless network is performing.

Abstract: Compounds are provided for inhibition of MEK that comprise: wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds.

Abstract: This invention relates to compounds that bind to mineralocorticoid receptors and/or modulate activity of mineralocorticoid receptors, and to methods for making and using such compounds. Some embodiments relate to compounds of Formula I: or a pharmaceutically acceptable salt, ester, amide, or prodrug thereof, wherein R1 —R10 are as defined herein.

Abstract: Compounds, pharmaceutical compositions, kits and methods are provided for use with MEK that comprise a compound selected from the group consisting of: wherein the variables are as defined herein.

Abstract: A system and method for monitoring performance of a wireless network. A probe server controls posts to send and receive probes of the wireless network. These probes provide feedback information, which indicates how the wireless network is performing.

Abstract: A system and method for monitoring performance of a wireless network are disclosed. According to one described example, at least one probe is generated. In the example, the probe determines the portion of a wireless network to monitor, the type of the probe, and the number and frequency of the probe or probes to target a specific carrier, a specific system, or a specific geographical area. A probe server generates the probe based on a parameter specified by the user and transmits the probe to a plurality of posts or to the wireless network. In the example, the probe server controls the posts to send and receive probes to the wireless network. In response to the received probes, the wireless network responds by sending feedback information, which can be used to indicate how the wireless network is performing.